RhumbLine Advisers’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $225K | Buy |
|
|||||
|
2025
Q1 | $317K | Sell |
|
|||||
|
2024
Q4 | $366K | Sell |
|
|||||
|
2024
Q3 | $552K | Sell |
|
|||||
|
2024
Q2 | $614K | Sell |
|
|||||
|
2024
Q1 | $616K | Sell |
|
|||||
|
2023
Q4 | $571K | Sell |
|
|||||
|
2023
Q3 | $485K | Sell |
|
|||||
|
2023
Q2 | $1.34M | Buy |
|
|||||
|
2023
Q1 | $1.42M | Buy |
|
|||||
|
2022
Q4 | $1.36M | Buy |
|
|||||
|
2022
Q3 | $1.08M | Buy |
|
|||||
|
2022
Q2 | $978K | Buy |
|
|||||
|
2022
Q1 | $1.08M | Buy |
|
|||||
|
2021
Q4 | $1.51M | Sell |
|
|||||
|
2021
Q3 | $1.8M | Sell |
|
|||||
|
2021
Q2 | $2.03M | Sell |
|
|||||
|
2021
Q1 | $2.07M | Buy |
|
|||||
|
2020
Q4 | $2.2M | Buy |
|
|||||
|
2020
Q3 | $1.55M | Sell |
|
|||||
|
2020
Q2 | $1.76M | Sell |
|
|||||
|
2020
Q1 | $1.45M | Buy |
|
|||||
|
2019
Q4 | $2.47M | Buy |
|
|||||
|
2019
Q3 | $2.46M | Buy |
|
|||||
|
2019
Q2 | $1.75M | Buy |
|
|||||
|
2019
Q1 | $1.29M | Buy |
|
|||||
|
2018
Q4 | $1.42M | Buy |
|
|||||
|
2018
Q3 | $1.52M | Buy |
|
|||||
|
2018
Q2 | $1.15M | Buy |
|
|||||
|
2018
Q1 | $1.68M | Buy |
|
|||||
|
2017
Q4 | $1.79M | Buy |
|
|||||
|
2017
Q3 | $1.64M | Buy |
|
|||||
|
2017
Q2 | $1.37M | Buy |
|
|||||
|
2017
Q1 | $1.2M | Buy |
|
|||||
|
2016
Q4 | $953K | Buy |
|
|||||
|
2016
Q3 | $906K | Buy |
|
|||||
|
2016
Q2 | $948K | Sell |
|
|||||
|
2016
Q1 | $831K | Buy |
|
|||||
|
2015
Q4 | $686K | Buy |
|
|||||
|
2015
Q3 | $534K | Buy |
|
|||||
|
2015
Q2 | $548K | Buy |
|
|||||
|
2015
Q1 | $680K | Buy |
|
|||||
|
2014
Q4 | $590K | Sell |
|
|||||
|
2014
Q3 | $544K | Buy |
|
|||||
|
2014
Q2 | $667K | Sell |
|
|||||
|
2014
Q1 | $614K | Sell |
|
|||||
|
2013
Q4 | $593K | Buy |
|
|||||
|
2013
Q3 | $311K | Buy |
|
|||||
|
2013
Q2 | $221K | Buy |
|